近日,AI制药公司Proxima(前身为VantAI)宣布完成了超额认购的8000万美元(约合人民币5.5亿元)种子轮,本轮融资由DCVC主导,参与者包括英伟达的风险投资部门NVentures、被称为创新药“捡漏王”的Roivant等。这家公司主打AI驱动的邻近式疗法(proximity therapeutics),这类疗法通过控制蛋白质之间的相互作用来工作,而不仅仅是抑制或激活单一靶点,代表类型...
Source Link近日,AI制药公司Proxima(前身为VantAI)宣布完成了超额认购的8000万美元(约合人民币5.5亿元)种子轮,本轮融资由DCVC主导,参与者包括英伟达的风险投资部门NVentures、被称为创新药“捡漏王”的Roivant等。这家公司主打AI驱动的邻近式疗法(proximity therapeutics),这类疗法通过控制蛋白质之间的相互作用来工作,而不仅仅是抑制或激活单一靶点,代表类型...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.